Why did Kobayashi become a target for activism now?

Oasis lifted its stake to 13.74% after the red yeast supplement recall raised questions about oversight and communication. That created an opening for change at the board level. Japan shareholder activism has grown, and a concentrated holder can influence proposals if other investors agree on governance and return priorities.

Is Kobayashi Pharmaceutical stock expensive or cheap today?

At ¥5,269, the stock trades at 34.47x TTM earnings, 1.88x book, and 2.44x sales. Balance sheet strength is clear, but FY2024 saw revenue and EPS decline. Value depends on confidence in a recovery and governance improvements. A sustained margin rebuild and stable cash returns would support the current multiple.

What could happen at the March AGM?

Investors may see proposals for more independent directors, stronger risk controls around health products, and a clearer capital return stance. If a proxy fight develops, board seats could shift. The market will weigh the credibility of reforms and the vote outcome when reassessing the stock’s risk and valuation.

What price levels should I watch into the AGM proxy fight?

Key supports are near the 50-day average around ¥5,263 and the Bollinger lower band near ¥5,188. Resistance sits near ¥5,337 and the 52-week high at ¥6,350. Watch volume versus the 234,649 average and momentum gauges like RSI 58.88 for confirmation of breakouts or fades.

Global Market Insights

4967.T Stock Today: Oasis Becomes Top Holder, AGM Showdown — December 28

ByHuzaifa Zahoor December 27, 2025December 27, 2025

Kobayashi Pharmaceutical stock (4967.T) closed at ¥5,269, down 1.29% today, as Oasis Management lifted its stake to 13.74% and became the largest shareholder after the red yeast supplement scandal. The move sets up a high-stakes March AGM where board changes may be proposed, raising the odds of an AGM proxy fight and a governance reset. Tokyo investors are weighing ownership shifts with fundamentals and technicals as headlines build into March, per Bloomberg’s report source.